We also found that the risk score was positively correlated with HCC-related HALLMARK signaling pathways such as mTORC1, PI3K/AKT/mTOR, and p53, suggesting that the poor prognosis of patients may be the result of a combination of multiple oncogenic pathways (Figure 3D). This evidence concerns the gene MTOR and hepatocellular carcinoma.